These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

969 related articles for article (PubMed ID: 29770269)

  • 1. Ten years of progress and promise of induced pluripotent stem cells: historical origins, characteristics, mechanisms, limitations, and potential applications.
    Omole AE; Fakoya AOJ
    PeerJ; 2018; 6():e4370. PubMed ID: 29770269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration-free reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) without viral vectors, recombinant DNA, and genetic modification.
    Heng BC; Fussenegger M
    Methods Mol Biol; 2014; 1151():75-94. PubMed ID: 24838880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An insight into non-integrative gene delivery approaches to generate transgene-free induced pluripotent stem cells.
    Haridhasapavalan KK; Borgohain MP; Dey C; Saha B; Narayan G; Kumar S; Thummer RP
    Gene; 2019 Feb; 686():146-159. PubMed ID: 30472380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Induced pluripotent stem cell technology and its application in disease research].
    Cai CY; Meng FL; Rao L; Liu YY; Zhao XL
    Yi Chuan; 2020 Nov; 42(11):1042-1061. PubMed ID: 33229312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current advances in the generation of human iPS cells: implications in cell-based regenerative medicine.
    Revilla A; González C; Iriondo A; Fernández B; Prieto C; Marín C; Liste I
    J Tissue Eng Regen Med; 2016 Nov; 10(11):893-907. PubMed ID: 25758460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced Pluripotent Stem Cells and Induced Pluripotent Cancer Cells in Cancer Disease Modeling.
    Zhu D; Kong CSL; Gingold JA; Zhao R; Lee DF
    Adv Exp Med Biol; 2018; 1119():169-183. PubMed ID: 30069853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Insight into DNA-free Reprogramming Approaches to Generate Integration-free Induced Pluripotent Stem Cells for Prospective Biomedical Applications.
    Borgohain MP; Haridhasapavalan KK; Dey C; Adhikari P; Thummer RP
    Stem Cell Rev Rep; 2019 Apr; 15(2):286-313. PubMed ID: 30417242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
    Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
    J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs.
    Menon S; Shailendra S; Renda A; Longaker M; Quarto N
    Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducing pluripotency in vitro: recent advances and highlights in induced pluripotent stem cells generation and pluripotency reprogramming.
    Rony IK; Baten A; Bloomfield JA; Islam ME; Billah MM; Islam KD
    Cell Prolif; 2015 Apr; 48(2):140-56. PubMed ID: 25643745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current reprogramming systems in regenerative medicine: from somatic cells to induced pluripotent stem cells.
    Hu C; Li L
    Regen Med; 2016 Jan; 11(1):105-32. PubMed ID: 26679838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery.
    Singh VK; Kalsan M; Kumar N; Saini A; Chandra R
    Front Cell Dev Biol; 2015; 3():2. PubMed ID: 25699255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Derivation of Human Induced Pluripotent Stem Cell (iPSC) Lines and Mechanism of Pluripotency: Historical Perspective and Recent Advances.
    Chhabra A
    Stem Cell Rev Rep; 2017 Dec; 13(6):757-773. PubMed ID: 28918520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Integrating and Non-Integrating Reprogramming Methods on Copy Number Variation and Genomic Stability of Human Induced Pluripotent Stem Cells.
    Kang X; Yu Q; Huang Y; Song B; Chen Y; Gao X; He W; Sun X; Fan Y
    PLoS One; 2015; 10(7):e0131128. PubMed ID: 26131765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of somatic cell reprogramming using the microRNA miR-302.
    Kelley K; Lin SL
    Prog Mol Biol Transl Sci; 2012; 111():83-107. PubMed ID: 22917227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in understanding the cell types and approaches used for generating induced pluripotent stem cells.
    Li J; Song W; Pan G; Zhou J
    J Hematol Oncol; 2014 Jul; 7():50. PubMed ID: 25037625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic remodeling during somatic cell reprogramming to induced pluripotent stem cells: involvement of hypoxia-inducible factor 1.
    Ishida T; Nakao S; Ueyama T; Harada Y; Kawamura T
    Inflamm Regen; 2020; 40():8. PubMed ID: 32426078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies to generate induced pluripotent stem cells.
    Hayes M; Zavazava N
    Methods Mol Biol; 2013; 1029():77-92. PubMed ID: 23756943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.